Fresenius Kabi Canada Partners with HPIC to Improve Childbirth Health Outcomes in Haiti

Fresenius Kabi Canada has partnered with Health Partners International of Canada (HPIC), Plan International Canada and a number of other pharmaceutical and healthcare companies in a program aimed to improve access to healthcare for women and girls in Haiti, who are at risk of mortality during and following childbirth.

Plan International Canada developed a project called SHOW (Strengthening Health Outcomes for Women and Children). SHOW is a multi-year, multi-country project to improve access to healthcare for women and girls. HPIC is a partner in the Haiti component of the project funded by Global Affairs Canada. Donations by the partners include: antibiotics, anesthetics, antifungals, anti-hypertensives, diuretics, anti-malarials, medicines for reflux and pain relief.

Haiti has the highest maternal mortality rate in the Americas, and this program is expected to help over 100,000 women, their partners and children, by providing desperately-needed medications.

At a recent event, representatives from the partnering organizations came to HPIC’s distribution centre in Oakville to learn more about how they are helping to #ChangetheBirthStory and to see the skids packed and ready for pick up. Linda Campbell, HPIC’s Director of Product Planning thanked the donors for their contributions to filling the skids for transport to Haiti.

“We are eternally grateful to the pharmaceutical and healthcare companies in Canada who make this relief possible. This project will contribute to saving lives now and will make a lasting impact over the years. Saving the life of a mother gives hope to her community.”

#ChangetheBirthStory

Participating pharmaceutical and healthcare companies include: Fresenius Kabi Canada, AstraZeneca Canada, Beckton & Dickinson, Henry Schein, Johnson & Johnson Inc., Pfizer Canada Inc., Pharmascience Inc., Teligent and Teva Canada Limited.

“We at Fresenius Kabi Canada are honoured to be able to contribute to this important initiative,” said Matthew Rotenberg, CEO of Fresenius Kabi Canada. “It is critical for the health of women and children in Haiti, and it is part of our corporate commitment to Caring for Life.”

Fresenius Kabi Canada has been a proud supporter of HPIC since 1998.